Network Penetration Testing for Biotech companies in Wilmington (DE)
Network Penetration Testing for Biotech Companies in Wilmington, DE
Biotech organizations in Wilmington and across Delaware handle some of the most sensitive data in the region — from clinical trial results and proprietary formulations to genomic data and protected health information (PHI). This makes local biotech labs, contract research organizations (CROs), and life science startups attractive targets for ransomware groups, nation‑state actors, and insider threats.
Common attack methods include phishing emails, malware infections, stolen passwords, SQL injection attacks, and targeted ransomware campaigns. The financial impact is substantial: in 2021, the median cost of a data breach reached $4.24M (source)—and that figure reflects only incidents that were publicly reported.
For biotech organizations working under FDA, HIPAA, GxP, and ISO-driven requirements, the message is simple: cybersecurity controls must be tested, not assumed. Regular network penetration testing provides leadership with clear, evidence‑based insight into how well current defenses protect:
Research networks supporting lab instruments (LIMS, ELN, sequencing platforms, and OT/IoT lab devices)
Corporate environments such as email, file shares, and collaboration tools handling sensitive IP
Cloud and hybrid systems used for data analytics, clinical data management, and bioinformatics
Network penetration testing (or “net‑pen testing”) is a controlled, ethical hacking exercise in which security professionals simulate real attackers attempting to compromise your environment. The goal is to find and safely exploit weaknesses before criminals do, then provide clear remediation guidance your IT and security teams can act on.
Wilmington Biotech Network Penetration Testing Experience
OCD Tech provides network penetration testing services to biotech and life science companies in Wilmington and across Delaware. Our team combines hands‑on penetration testing experience with deep knowledge of regulated environments and sensitive research workloads.
We routinely work with organizations such as:
Biotech and pharmaceutical research companies
Clinical research sites and CROs
Medical device and diagnostics developers
Healthcare‑adjacent technology and data analytics firms
Our approach goes beyond simply running tools and handing over a report. Each engagement is designed to:
Identify real‑world attack paths to your IP, PHI, and critical lab systems
Validate the effectiveness of existing controls, including firewalls, EDR, MFA, and segmentation between lab and corporate networks
Support compliance efforts tied to HIPAA, FDA expectations, GxP, SOC 2, and other frameworks relevant to biotech operations
Provide prioritized, actionable remediation steps your internal IT and security teams can execute
The result is a practical security assessment that strengthens your security posture without disrupting day‑to‑day lab operations.
Network Penetration Testing Methodology
OCD Tech follows a structured, repeatable penetration testing methodology aligned with industry best practices. While every biotech environment is unique, our assessments typically include the following phases:
Passive Reconnaissance – Quietly gather information about your public‑facing presence, domains, and exposed services without directly engaging your systems.
Active Reconnaissance – Scan and map network ranges, hosts, and services to understand how your environment is structured, including lab networks and cloud integrations.
Social Engineering – Where in scope, test user awareness through controlled phishing or phone‑based attempts to gain access or information, mirroring how attackers often first enter biotech organizations.
Exploitation – Attempt to exploit discovered weaknesses, misconfigurations, and missing patches to gain footholds on servers, workstations, or lab systems.
Post‑Exploitation – Assess what an attacker could do after initial compromise, such as accessing research data, sensitive file shares, or credentials.
Privilege Escalation – Try to increase access from standard user accounts to administrative or domain‑level control, demonstrating potential blast radius.
Lateral Movement – Move between systems and segments (e.g., from corporate workstations toward lab networks or cloud resources) to identify gaps in network segmentation.
Maintaining Access – Show how an attacker could persist in your environment, even after a basic cleanup, if certain controls are missing.
Covering Tracks – Evaluate log visibility and monitoring by reviewing how detectable actions are to your blue team and security tools.
Reporting & Executive Debrief – Deliver a clear, non‑technical executive summary, detailed technical findings, and prioritized remediation recommendations, with specific attention to protecting biotech IP and regulated data.
This methodology can support different testing models, including assumed compromise (starting with limited internal access) and collaborative purple team exercises with your security operations staff.
National Reach
While we actively support the biotech and life sciences community in Wilmington and greater Delaware, OCD Tech also provides network penetration testing and security assessments to organizations across the U.S., including:
Many biotech and life science firms operate across multiple sites and states; our team is equipped to deliver consistent, coordinated penetration testing across your full footprint.
Contact Our Wilmington Network Penetration Testing Consultants
OCD Tech provides network penetration testing, ethical hacking, and cybersecurity consulting to biotech and life science organizations in Wilmington and across Delaware. If you would like to discuss how a targeted penetration test can help protect your research, IP, and regulated data, please complete the form below and a team member will follow up with you shortly.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)